ISSN 2208-150X (Print)
ISSN 2208-1518 (Online)
THE BEST OF ESC 2017
The Interleukin-1β Inhibitor Canakinumab Cuts Cardiovascular Disease and Lung Cancer Risk by Reducing
Inflammation – CANTOS Trial • Renal Denervation Lowers Blood Pressure in Hypertensive Patients Not Taking
Antihypertensive Medication – SPYRAL HTN-OFF MED Trial • Catheter Ablation Improves Outcomes in Patients With
Heart Failure and Atrial Fibrillation – CASTLE-AF Trial • Two Results of the PURE Study May Be Game Changers in
Heart Disease Prevention
This ESC Congress 2017 PracticeUpdate Conference Series is
distributed with the support of A. Menarini Australia.
EUROPEAN SOCIETY OF CARDIOLOGY
CONGRESS 2017
26–30 AUGUST 2017 • BARCELONA, SPAIN